SCHEMBL7742019

SCHEMBL7742019

Cc1c(C(=O)CBr)c[nH]c1-c1ccncc1

nearest known ligand 0.45

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CSNK1A1 P48729 1/20 0.45
CSNK1D P48730 1/20 0.45
CLK2 P49760 1/20 0.45
CSNK1G1 Q9HCP0 1/20 0.45
CCNC P24863 5/20 0.42
CDK8 P49336 5/20 0.42
AXL P30530 1/20 0.39
CDC7 O00311 8/20 0.38
GCGR P47871 1/20 0.36
GSK3B P49841 1/20 0.35
IMPDH2 P12268 1/20 0.34
MAPT P10636 1/20 0.34
ALDH1A1 P00352 1/20 0.34
CCNA2 P20248 1/20 0.34
CDK2 P24941 1/20 0.34
CCNA1 P78396 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7690501 0.81 CSNK1A1 (0.58) CSNK1A1CSNK1DCLK2CSNK1G1CCNC
SCHEMBL31295156 0.68 NAMPT (0.46) IMPDH2ALDH1A1
SCHEMBL1889779 0.67 TDP1 (0.46) CCNCCDK8GSK3BMAPTALDH1A1
SCHEMBL3812402 0.67 TDP1 (0.59) CCNCCDK8GSK3BMAPTALDH1A1
Hydrochloric Acid SCHEMBL641566 0.66 TDP1 (0.58) CCNCCDK8GSK3BMAPTALDH1A1
Bromide SCHEMBL5567775 0.66 TDP1 (0.58) CCNCCDK8GSK3BMAPTALDH1A1
SCHEMBL7683073 0.66 SMN1; SMN2 (0.51) CSNK1A1CSNK1DCLK2CSNK1G1AXL
SCHEMBL23204597 0.66 MAP2K1 (0.38) CSNK1A1CSNK1DCLK2CDK8AXL
SCHEMBL7689328 0.66 CSNK1A1 (0.69) CSNK1A1CSNK1DCLK2CSNK1G1CCNC
Bromide SCHEMBL9203773 0.65 GSK3B (0.63) GSK3BMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6417202-B1 3-ACETYL-4-METHYL-2,5-DI(4-PYRIDYL)-1H-PYRROLE, FOR EXAMPLE; TREATING CELL ADHESION MOLECULES (CAMS) MEDIATED DISEASES SUCH AS ARTHRITIS, AIDS, SEPTIC SHOCK, CACHEXIA, TRANSPLANT REJECTION PFIZER INC. 2002-07-09 US disclosed